- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07353021
Langtidseffekter av en biofelt-patch på angst, søvn og energi
Klinisk studie om langsiktige effekter av et biofelt-plaster på angst, søvn og energi. En randomisert dobbeltblind placebokontrollert 4-ukers studie.
The goal for this clinical trial is to compare an active biofield non-transdermal skin patch to a placebo patch in people who frequently experience anxiety.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The goal for this clinical trial is to document effects of a photobiomodulating non-transdermal patch compared to a placebo patch, in a randomized double-blind placebo-controlled design.
Data on stress and anxiety levels will be collected using the GAD and OASIS questionnaires as well as the Warwick-Edinburgh Mental Wellbeing Scales collected. The data collected will show whether the daily use of the patch leads to a change in general self-reported stress and anxiety levels. Data on energy levels will be collected using a Wellness questionnaire. Data on sleep quality will be collected using the Leeds sleep evaluation questionnaire, to document whether using the active patch impacts self-reported sleep.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Alex Cruickshank
- E-post: Alex@nislabs.com
Studer Kontakt Backup
- Navn: Gitte S Jensen, PhD
- Telefonnummer: 541 882 0112
- E-post: Gitte@nislabs.com
Studiesteder
-
-
Oregon
-
Klamath Falls, Oregon, Forente stater, 97601
- Rekruttering
- NIS Labs
-
Ta kontakt med:
- Gitte S. Jensen, PhD
- Telefonnummer: 5418840112
- E-post: gitte@nislabs.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
Healthy adults of all genders;
-
Age 18-75 years (inclusive);
-
BMI between 18.0 and 34.9 (inclusive)
-
Experiencing intermittent episodes of anxiety on a regular basis, leading to either avoiding specific situations, or experiencing stress both in anticipation of, and during such situations.
-
Specific situations that occur regularly that cause anxiety, for example:
- Performing specific tasks at work or at home;
- Inter-personal conflicts at work or at home;
- Driving or commuting;
- Fearful and worrying about one's own situation (such as paying bills);
- Worrying about ongoing problems experienced by others.
-
Exclusion Criteria:
- Cancer during past 12 months;
- Chemotherapy during past 12 months;
- Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication;
- Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
- Participation in another clinical trial study during this trial, involving an investigational product or lifestyle change;
- Serious active illness within past 6 months;
- People who are pregnant, nursing, or trying to become pregnant.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Group 1
Participants will use an active biofield patch daily for 4 weeks. The active biofield patch will look identical to a placebo patch, and will be blinded. |
Non-transdermal patch |
|
Eksperimentell: Group 2
Participants will use a placebo patch daily for 4 weeks. The placebo patch will look identical to an active patch, and will be blinded. |
Non-transdermal patch |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
General Anxiety Disorder 7 (GAD 7) Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Change from baseline in anxiety score using the General Anxiety Disorder 7-item. The General Anxiety Disorder-7 scale evaluates anxiety severity using scores ranging from 0-21, where higher scores indicate higher anxiety severity. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overal Anxiety Severity and Impairment Scale (OASIS) Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Change from baseline in Overall Anxiety Severity and Impairment Scale (OASIS) score. The Overall Anxiety Severity and Impairment scale evaluates anxiety and impact on daily living in participants with a score between 0 and 25, where higher scores indicate higher anxiety severity and impact on daily living. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Warwick-Edinburgh Mental Wellbeing Scale
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Changes from baseline in mental wellbeing using the Warwick-Edinburgh Mental Wellbeing scale. The Warwick-Edinburgh Mental Wellbeing scale evaluates self reported happiness and satisfaction as well as psychological functioning, good relationships with others, and self realization. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
|
Wellness Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Change from baseline in wellness evaluated using a Wellness questionnaire. The Wellness questionnaire consists of 30 questions, generating scores for physical, mental functioning, emotional wellbeing, stress, social functioning, sleep, and energy/vitality, where higher scores reflect better wellness. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
|
Leeds Sleep Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks.
|
Changes from baseline in sleep quality. The Leeds Sleep Evaluation Questionnaire is a 10 item linear-log scale based on questions across several domains of sleep, where higher scores reflect better sleep quality |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks.
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 206-008
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .